Monday, August 3, 2015

Ex-Synthes exec Walsh said to be withdrawing appeal

Ex-Synthes executive John Walsh apparently will not appeal his five-month prison sentence for his involvement in an illegal clinical trial of bone cement.

Ex-Synthes exec Walsh said to be withdrawing appeal


Former Synthes executive John Walsh was on the road to appealing his five-month prison sentence for involvement in an illegal clinical trial of bone cement, which was used by surgeons during back operations, three of which ended in patients dying on the table.

However, in a Tuesday court filing, one of his attorneys said Walsh is reconsidering whether to appeal his sentence.

Though Walsh did not speak at his sentencing hearing Nov. 21, his attorneys were among the first and most ardent in arguing that Walsh's First Amendment rights were infringed upon by the government prosecuting him and three other executives for promoting the bone cement even though it had not been approved by the U.S. Food and Drug Administration.

The First Amendment line of thought stems from this past summer when the Supreme Court ruled in another case that pharmaceutical companies and other business have rights to market their products. Walsh's defense team even added an attorney who specializes in appeals court arguments.

However, Walsh did plead guilty and his sentence was within the guidelines of federal sentencing rules.

And that new attorney, Jeremy C. Marwell, filed Tuesday's letter to the court, asking for time for Walsh to file his formal withdrawal.

"I write to bring to the Court's attention that Mr. Walsh now wishes to withdraw his appeal," Marwell said in the filing.

We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at

David Sell
Also on
letter icon Newsletter